Physician profile
Antonio Murtinho
NPI 1134294689
$3,974.53
in general payments reported to CMS, 2019-2025
16 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $214 · 2021: $225 · 2022: $439 · 2023: $644 · 2024: $1,784 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,400 · Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,400.00 |
| Food and Beverage | $1,214.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Instrumentation Laboratory Company | $1,400.00 | 2024 | |
| Abbvie INC. | $648.07 | 2021-2025 | |
| Allergan, INC. | $341.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $247.97 | 2019-2023 | Xarelto |
| Pfizer INC. | $212.53 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $204.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $160.47 | 2020-2023 | Farxiga |
| Biotronik INC. | $147.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $141.67 | 2019-2023 | Eliquis |
| Aimmune Therapeutics, INC. | $125.00 | 2024 | |
| Viiv Healthcare Company | $121.84 | 2024 | |
| Paratek Pharmaceuticals, INC. | $101.15 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $46.35 | 2019 | |
| Merck Sharp & Dohme LLC | $36.09 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $22.60 | 2023 | Inpefa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.76 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Murtinho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.